Atypical Burkitt lymphoma arising from follicular lymphoma: Demonstration by polymerase chain reaction following laser capture microdissection and by fluorescence in situ hybridization on paraffin-embedded tissue sections

American Journal of Surgical Pathology

Volumn 29, Issue 1, 2005, Pages 121-124

  Tomita, Naoto ^a,d   Nakamura, Naoya ^b   Kanamori, Heiwa ^a   Fujimaki, Katsumichi ^e   Fujisawa, Shin ^a   Ishigatsubo, Yoshiaki ^a   Nomura, Kenichi ^c  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^e NONE

Author keywords

Composite lymphoma; Laser capture microdissection; Polymerase chain reaction; t(14; 18); t(8; 14); Tissue fluorescence in situ hybridization

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; PARAFFIN; PROTEIN BCL 2;

AGED; ARTICLE; BURKITT LYMPHOMA; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; HUMAN; LASER CAPTURE MICRODISSECTION; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; ONCOGENE C MYC; POLYMERASE CHAIN REACTION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASE SEQUENCE; BURKITT LYMPHOMA; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 8; FATAL OUTCOME; GENES, BCL-2; GENES, IMMUNOGLOBULIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LASERS; LYMPHOMA, FOLLICULAR; MALE; MICRODISSECTION; MOLECULAR SEQUENCE DATA; NEOPLASMS, SECOND PRIMARY; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 11144271969     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000146027.76706.50     Document Type: Article

References (15)

1. A predictive model for aggressive non-Hodgkin's lymphoma: the International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987-994.
2. Cory S, Vaux DL, Strasser A, et al. Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res. 1999;59:1685-1692.
3. De Jong D, Voetdijk BM, Beverstock GC, et al. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med. 1988;318:1373-1378.
4. Fifth International Workshop on Chromosomes in Leukemia Lymphoma. Correlation of chromosome abnormalities with histologic and immunologic characteristics in non-Hodgkin's lymphoma and adult T cell leukemia lymphoma. Blood. 1987;70:1554-1564.
5. Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In: World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2001.
6. Karsan A, Gascoyne RD, Coupland RW, et al. Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies. Leuk Lymphoma. 1993;10:433-441.
7. Lee JT, Innes DJ Jr, Williams ME. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. J Clin Invest. 1989;84:1454-1459.
8. Moskaluk C, Kern SE. Microdissection and polymerase chain reaction amplification of genomic DNA from histologic tissue sections. Am J Pathol. 1997;150:1547-1552.
9. Nakamura N, Kuze T, Hashimoto Y, et al. Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive and -negative diffuse large B cell lymphoma. Leukemia. 2001;15:452-457.
10. Nomura K, Sekoguchi S, Ueda K, et al. Differentiation of follicular from mucosa-associated lymphoid tissue lymphoma by detection of t(14;18) on single-cell preparations and paraffin-embedded sections. Gene Chromosomes Cancer. 2002;33:213-216.
11. Nomura K, Yoshino T, Nakamura S, et al. Detection of t(11;18)(q21;q21) in marginal zone lymphoma of mucosa-associated lymphocytic tissue type on paraffin-embedded tissue sections by using fluorescence in situ hybridization. Cancer Genet Cytogenet. 2003;140:49-54.
12. Offit K, Jhanwar SC, Ladanyi M, et al. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosomes Cancer. 1991;3:189-201.
13. Tomita N, Kodama F, Kanamori H, et al. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system relapse and improves survival in aggressive non-Hodgkin's lymphoma. Cancer. 2002;95:576-580.
14. Yunis JJ, Frizzera G, Oken MM, et al. Multiple recurrent genomic defects in follicular lymphoma. N Engl J Med. 1987;316:79-84.
15. Weiss LM, Warnke RA, Sklar J, et al. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med. 1987;317:1185-1189.